Kymera Therapeutics, Inc. (KYMR)
87.40
+0.90
(+1.04%)
USD |
NASDAQ |
Feb 20, 16:00
88.88
+1.48
(+1.69%)
After-Hours: 20:00
Kymera Therapeutics Price : 87.40 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 779.67 |
| Gilead Sciences, Inc. | 151.40 |
| Eli Lilly & Co. | 1009.52 |
| Cytokinetics, Inc. | 67.94 |
| Travere Therapeutics, Inc. | 30.39 |
Price Related Metrics
| PS Ratio | 163.81 |
| PEG Ratio | -0.4461 |
| Price to Book Value | 6.646 |
| Earnings Yield | -4.11% |
| Market Cap | 6.288B |
| PEGY Ratio | -0.4461 |